Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.9 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.41.
Market Cap
9.9T
Revenue
4.74T
Profits
213.25B
PE Ratio
46.41
Profit Margin
4.50%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.21T | -0.72% | 2,822,932 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 665.00B | 1.44% | 8,859,975 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 515.21B | 1.12% | 5,017,773 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 361.97B | -0.07% | 7,462,075 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 353.28B | -0.36% | 5,751,512 | 450.06B |
| 6 | NVS | Novartis AG | 306.89B | 0.47% | 1,995,676 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 288.13B | -0.21% | 2,846,845 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 257.89B | 2.82% | 2,090,749 | 47.35B |
| 9 | AMGN | Amgen Inc. | 248.88B | -0.03% | 2,579,506 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.02B | -0.39% | 5,661,395 | 30.99B |
| 11 | ABT | Abbott Laboratories | 190.43B | -3.21% | 8,345,272 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 177.23B | 0.02% | 9,220,316 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.49B | -0.22% | 48,291,809 | 63.62B |
| 14 | DHR | Danaher Corporation | 162.02B | 1.75% | 4,061,108 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.94B | -3.37% | 2,150,468 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.67B | 0.82% | 1,271,310 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.13B | -1.48% | 9,794,849 | 50.03B |
| 18 | MDT | Medtronic plc | 124.71B | -2.83% | 7,451,178 | 37.54B |
| 19 | SYK | Stryker Corporation | 124.07B | -2.73% | 3,778,577 | 26.30B |
| 20 | MCK | McKesson Corporation | 122.45B | -1.07% | 812,138 | 418.79B |
| 21 | SNY | Sanofi | 111.93B | 0.28% | 3,885,308 | 57.89B |
| 22 | CVS | CVS Health Corporation | 107.31B | 3.12% | 14,039,346 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 103.33B | -2.53% | 1,462,209 | 78.70B |
| 24 | MRNA | Moderna, Inc. | 101.47B | 5.26% | 16,266,848 | 2.53B |
| 25 | GSK | GSK plc | 101.10B | -0.16% | 3,185,245 | 44.53B |
| 26 | ELV | Elevance Health, Inc. | 91.98B | -1.45% | 1,444,695 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 90.75B | 0.17% | 1,122,266 | 16.90B |
| 28 | CI | The Cigna Group | 77.40B | -2.57% | 2,429,865 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 65.63B | -0.83% | 2,965,881 | 29.86B |
| 30 | COR | Cencora, Inc. | 63.62B | -1.85% | 1,682,048 | 337.40B |
| 31 | CAH | Cardinal Health, Inc. | 62.65B | 1.21% | 1,980,788 | 257.75B |
| 32 | BSX | Boston Scientific Corporation | 61.99B | -4.19% | 11,755,417 | 21.07B |
| 33 | ARGX | argenx SE | 59.03B | 3.78% | 378,196 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 58.72B | 1.29% | 5,112,591 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 57.77B | -0.68% | 2,172,572 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 53.28B | 0.83% | 588,954 | 4.66B |
| 37 | MDLN | Medline Inc. | 52.20B | -0.19% | 8,947,658 | 30.68B |
| 38 | HUM | Humana Inc. | 52.09B | 5.34% | 2,570,898 | 154.19B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.71B | 1.96% | 6,191,017 | 17.23B |
| 40 | VEEV | Veeva Systems Inc. | 49.27B | -1.86% | 1,504,217 | 3.46B |
| 41 | A | Agilent Technologies, Inc. | 49.27B | 1.73% | 2,048,446 | 7.37B |
| 42 | ONC | BeOne Medicines AG | 46.49B | 5.10% | 935,855 | 6.61B |
| 43 | NTRA | Natera, Inc. | 44.99B | -14.70% | 5,775,653 | 2.91B |
| 44 | WAT | Waters Corporation | 44.98B | 1.04% | 695,756 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 44.78B | 2.57% | 1,398,389 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.59B | 8.25% | 4,496,226 | 197.56M |
| 47 | HLN | Haleon plc | 39.76B | -0.16% | 18,678,530 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.60B | -0.40% | 4,836,501 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.25B | -1.62% | 4,181,192 | 21.64B |
| 50 | BIIB | Biogen Inc. | 36.73B | 1.86% | 1,002,121 | 10.30B |
| 51 | ALC | Alcon Inc. | 35.39B | -2.12% | 3,123,891 | 10.86B |
| 52 | CNC | Centene Corporation | 34.54B | -5.95% | 5,811,533 | 180.41B |
| 53 | MTD | Mettler-Toledo International Inc. | 34.50B | 2.54% | 350,585 | 4.20B |
| 54 | GMAB | Genmab A/S | 33.27B | 1.61% | 7,827,783 | 4.30B |
| 55 | RMD | ResMed Inc. | 33.12B | -1.61% | 1,697,993 | 5.73B |
| 56 | ZTS | Zoetis Inc. | 32.28B | -3.24% | 5,805,062 | 9.52B |
| 57 | ILMN | Illumina, Inc. | 32.20B | 2.40% | 2,064,396 | 4.54B |
| 58 | LH | Labcorp Holdings Inc. | 29.80B | 1.02% | 610,117 | 14.59B |
| 59 | PHG | Koninklijke Philips N.V. | 29.62B | -0.56% | 1,789,449 | 20.16B |
| 60 | DXCM | DexCom, Inc. | 29.62B | -5.96% | 3,937,212 | 5.10B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.11B | 0.29% | 945,179 | 11.84B |
| 62 | ROIV | Roivant Sciences Ltd. | 28.09B | 6.19% | 12,265,073 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 27.85B | 1.87% | 625,874 | 3.40B |
| 64 | INSM | Insmed Incorporated | 25.13B | 5.32% | 3,379,748 | 1.52B |
| 65 | STE | STERIS plc | 24.51B | -0.66% | 1,389,569 | 6.17B |
| 66 | INCY | Incyte Corporation | 24.40B | 1.45% | 1,485,767 | 6.01B |
| 67 | UTHR | United Therapeutics Corporation | 23.95B | -0.60% | 454,928 | 3.19B |
| 68 | VTRS | Viatris Inc. | 22.85B | 5.06% | 14,437,366 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 22.55B | -1.10% | 631,594 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.71B | 1.99% | 724,177 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.88B | -0.48% | 2,829,716 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.47B | -1.39% | 5,513,603 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.97B | -1.23% | 2,660,327 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.27B | 2.89% | 231,621 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.32B | 2.91% | 1,683,257 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 16.97B | 1.23% | 2,003,524 | 2.50B |
| 77 | ASND | Ascendis Pharma A/S | 16.86B | 1.31% | 883,780 | 1.20B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.66B | 3.02% | 1,507,456 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.19B | 7.91% | 1,063,687 | 3.98B |
| 80 | SOLV | Solventum Corporation | 15.35B | 3.59% | 3,168,390 | 8.16B |
| 81 | ICLR | ICON Public Limited Company | 15.33B | 1.49% | 1,379,673 | 8.23B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 3.24% | 887,560 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.47B | 0.01% | 3,157,336 | 945.54M |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.00B | 2.03% | 2,482,829 | 15.25B |
| 85 | TEM | Tempus AI, Inc. | 13.87B | 7.98% | 5,896,931 | 1.51B |
| 86 | EHC | Encompass Health Corporation | 13.50B | -2.63% | 1,177,206 | 6.34B |
| 87 | BAX | Baxter International Inc. | 13.34B | 0.53% | 6,194,653 | 11.61B |
| 88 | GKOS | Glaukos Corporation | 13.27B | 1.99% | 1,202,827 | 690.33M |
| 89 | SMMT | Summit Therapeutics Inc. | 13.08B | 15.22% | 5,783,927 | - |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.85B | 8.61% | 11,505,354 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.64B | -2.66% | 1,863,749 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.59B | -0.53% | 336,094 | 1.56B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.47B | 2.58% | 2,639,549 | 3.44B |
| 94 | FMS | Fresenius Medical Care AG | 12.22B | -1.10% | 1,088,674 | 22.12B |
| 95 | DVA | DaVita Inc. | 12.04B | -1.79% | 603,674 | 14.17B |
| 96 | COO | The Cooper Companies, Inc. | 11.86B | -1.81% | 2,059,763 | 4.24B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.77B | -15.64% | 6,162,578 | 1.80B |
| 98 | ALGN | Align Technology, Inc. | 11.71B | 4.21% | 1,756,229 | 4.16B |
| 99 | UHS | Universal Health Services, Inc. | 11.52B | -1.54% | 740,135 | 18.35B |
| 100 | TECH | Bio-Techne Corporation | 11.42B | 0.19% | 2,307,626 | 1.22B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.24B | 2.74% | 784,515 | 102.24M |
| 102 | RGEN | Repligen Corporation | 11.10B | 3.03% | 1,069,907 | 805.61M |
| 103 | MOH | Molina Healthcare, Inc. | 10.89B | -3.46% | 693,885 | 42.08B |
| 104 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | -0.14% | 2,733,184 | 3.66B |
| 105 | AVTR | Avantor, Inc. | 10.48B | 2.15% | 6,142,985 | 6.64B |
| 106 | ENSG | The Ensign Group, Inc. | 10.48B | -0.68% | 292,117 | 5.67B |
| 107 | QGEN | Qiagen N.V. | 10.39B | -1.06% | 3,394,153 | 2.12B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.28B | 3.57% | 218,779 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.17B | -6.10% | 1,567,696 | 3.19B |
| 110 | PCVX | Vaxcyte, Inc. | 10.10B | 3.08% | 1,840,628 | - |
| 111 | SYRE | Spyre Therapeutics, Inc. | 9.87B | 7.60% | 1,630,339 | - |
| 112 | HSIC | Henry Schein, Inc. | 9.52B | 0.93% | 1,375,031 | 13.73B |
| 113 | OSCR | Oscar Health, Inc. | 9.51B | -7.63% | 8,874,875 | 17.47B |
| 114 | GMED | Globus Medical, Inc. | 9.41B | -12.88% | 9,272,175 | 3.14B |
| 115 | BRKR | Bruker Corporation | 9.35B | 5.74% | 2,012,689 | 3.51B |
| 116 | HNGE | Hinge Health, Inc. | 9.35B | -0.15% | 1,226,742 | 800.82M |
| 117 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.28B | -0.10% | 1,040,088 | 1.43B |
| 118 | IBRX | ImmunityBio, Inc. | 9.15B | 7.80% | 8,348,391 | 165.79M |
| 119 | ATR | AptarGroup, Inc. | 9.04B | -1.01% | 505,062 | 3.99B |
| 120 | KRYS | Krystal Biotech, Inc. | 8.91B | 0.17% | 234,189 | 470.03M |
| 121 | HQY | HealthEquity, Inc. | 8.57B | 0.18% | 674,396 | 1.36B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.53B | -2.57% | 972,941 | 551.69M |
| 123 | TGTX | TG Therapeutics, Inc. | 8.48B | 3.16% | 2,304,343 | 799.54M |
| 124 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.22B | 1.18% | 1,363,144 | 669.50M |
| 125 | CORT | Corcept Therapeutics Incorporated | 7.97B | 1.66% | 1,406,611 | 963.65M |
| 126 | PACS | PACS Group, Inc. | 7.89B | -1.04% | 874,546 | 5.71B |
| 127 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.79B | 6.96% | 4,928,737 | 280.75M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 7.74B | 5.62% | 309,865 | 7.46M |
| 129 | TXG | 10x Genomics, Inc. | 7.73B | 2.19% | 4,522,631 | 618.58M |
| 130 | ALKS | Alkermes plc | 7.72B | 3.12% | 1,673,316 | 1.75B |
| 131 | TWST | Twist Bioscience Corporation | 7.58B | 0.20% | 2,054,726 | 431.80M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.50B | 1.87% | 827,117 | 5.33M |
| 133 | GRFS | Grifols, S.A. | 7.48B | -0.06% | 610,343 | 8.63B |
| 134 | CYTK | Cytokinetics, Incorporated | 7.48B | -3.20% | 2,032,041 | 113.29M |
| 135 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.37B | 6.16% | 514,200 | 945.96M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.27B | -2.65% | 9,774,760 | 1.05B |
| 137 | BLCO | Bausch + Lomb Corporation | 7.14B | 0.25% | 554,335 | 5.42B |
| 138 | AMRX | Amneal Pharmaceuticals, Inc. | 7.01B | 3.50% | 4,725,270 | 3.20B |
| 139 | AXSM | Axsome Therapeutics, Inc. | 6.96B | 1.97% | 717,815 | 865.27M |
| 140 | CHE | Chemed Corporation | 6.84B | -1.19% | 142,596 | 2.66B |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.81B | 7.04% | 1,070,210 | - |
| 142 | CGON | CG Oncology, Inc. | 6.74B | 17.28% | 3,661,477 | 6.17M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.58B | -0.10% | 1,575,958 | 1.56B |
| 144 | IONS | Ionis Pharmaceuticals, Inc. | 6.55B | 1.60% | 2,911,837 | 874.09M |
| 145 | IMVT | Immunovant, Inc. | 6.30B | 7.43% | 2,658,239 | - |
| 146 | BLTE | Belite Bio, Inc | 6.23B | 8.10% | 174,528 | - |
| 147 | KOD | Kodiak Sciences Inc. | 6.18B | 8.23% | 1,046,999 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.14B | 2.60% | 130,173 | 253.83M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.12B | 0.24% | 722,712 | 670.78M |
| 150 | HIMS | Hims & Hers Health, Inc. | 6.06B | 8.04% | 13,132,860 | 2.58B |
| 151 | TFX | Teleflex Incorporated | 6.00B | -0.62% | 948,141 | 2.26B |
| 152 | RDNT | RadNet, Inc. | 5.97B | -2.73% | 1,664,224 | 2.27B |
| 153 | MANE | Veradermics, Incorporated | 5.80B | 7.88% | 459,487 | - |
| 154 | DOCS | Doximity, Inc. | 5.79B | -2.03% | 4,293,022 | 661.58M |
| 155 | SRRK | Scholar Rock Holding Corporation | 5.71B | 3.10% | 2,096,404 | - |
| 156 | COGT | Cogent Biosciences, Inc. | 5.49B | 6.93% | 1,481,650 | - |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.47B | -0.34% | 898,822 | 1.16B |
| 158 | HAE | Haemonetics Corporation | 5.46B | -3.36% | 834,664 | 1.38B |
| 159 | WAY | Waystar Holding Corp. | 5.45B | -1.84% | 1,269,321 | 1.26B |
| 160 | SUPN | Supernus Pharmaceuticals, Inc. | 5.44B | -2.06% | 5,911,222 | 1.37B |
| 161 | GRAL | GRAIL, Inc. | 5.44B | 2.00% | 755,914 | 166.60M |
| 162 | BLLN | BillionToOne, Inc. | 5.38B | 1.50% | 993,159 | 436.87M |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 5.38B | 0.11% | 1,424,120 | 2.34B |
| 164 | LFST | LifeStance Health Group, Inc. | 5.24B | 2.53% | 4,924,486 | 1.68B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.23B | -2.68% | 354,017 | 1.61B |
| 166 | ERAS | Erasca, Inc. | 5.04B | 8.59% | 4,032,150 | - |
| 167 | LIVN | LivaNova PLC | 4.96B | -1.29% | 443,949 | 1.51B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.94B | 16.05% | 3,712,850 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.86B | 3.22% | 1,234,168 | 25.17M |
| 170 | DNTH | Dianthus Therapeutics, Inc. | 4.86B | 3.89% | 595,293 | 2.72M |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.77B | 1.64% | 1,012,200 | 651.03M |
| 172 | OPCH | Option Care Health, Inc. | 4.74B | 0.51% | 1,821,625 | 5.75B |
| 173 | MMED | MiniMed Group, Inc. | 4.71B | -7.88% | 7,478,342 | 3.22B |
| 174 | SHC | Sotera Health Company | 4.57B | 0.88% | 2,199,215 | 1.23B |
| 175 | HTFL | HeartFlow, Inc. | 4.56B | 0.94% | 969,792 | 212.07M |
| 176 | LEGN | Legend Biotech Corporation | 4.54B | 3.97% | 1,658,718 | 1.27B |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.53B | 4.25% | 3,333,525 | 298.01M |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.47B | 9.58% | 1,272,617 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.31B | 2.83% | 464,849 | 2.18B |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | -0.12% | 993,298 | 1.83B |
| 181 | CDNA | CareDx, Inc. | 4.12B | 2.80% | 1,084,202 | 497.40M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.11B | 9.41% | 3,194,720 | 10.35M |
| 183 | NVST | Envista Holdings Corporation | 4.04B | 0.92% | 3,234,799 | 2.88B |
| 184 | LQDA | Liquidia Corporation | 3.98B | -0.18% | 1,064,229 | 450.91M |
| 185 | ABCL | AbCellera Biologics Inc. | 3.85B | 6.83% | 2,207,504 | 66.17M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 3.95% | 867,646 | 7.50M |
| 187 | PLSE | Pulse Biosciences, Inc. | 3.79B | 0.04% | 428,195 | 1.49M |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.71B | 6.92% | 1,860,528 | -665.00K |
| 189 | STVN | Stevanato Group S.p.A. | 3.69B | 2.31% | 1,365,033 | 1.42B |
| 190 | ACAD | Acadia Pharmaceuticals Inc. | 3.67B | -0.02% | 1,770,846 | 1.20B |
| 191 | IOVA | Iovance Biotherapeutics, Inc. | 3.64B | 3.75% | 11,529,854 | 378.98M |
| 192 | OGN | Organon & Co. | 3.64B | 0.44% | 3,947,166 | 6.10B |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.62B | 2.95% | 2,129,301 | 53.81M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.62B | 10.31% | 969,631 | - |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.53B | 2.37% | 629,323 | 148.00K |
| 196 | IRON | Disc Medicine, Inc. | 3.50B | 0.43% | 717,525 | - |
| 197 | ACHC | Acadia Healthcare Company, Inc. | 3.44B | 6.35% | 4,533,735 | 3.41B |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.42B | 4.07% | 2,663,520 | - |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.39B | 1.78% | 864,963 | 682.20M |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.03% | 2,359,185 | - |
| 201 | TLX | Telix Pharmaceuticals Limited | 3.27B | 2.28% | 311,731 | 890.79M |
| 202 | CELC | Celcuity Inc. | 3.27B | 4.26% | 1,081,622 | - |
| 203 | NHC | National HealthCare Corporation | 3.26B | 0.30% | 433,992 | 1.58B |
| 204 | VRDN | Viridian Therapeutics, Inc. | 3.24B | -0.18% | 4,486,216 | 26.31M |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -5.41% | 3,262,158 | 508.68M |
| 206 | DNLI | Denali Therapeutics Inc. | 3.22B | 1.72% | 1,586,646 | 21.38M |
| 207 | WRBY | Warby Parker Inc. | 3.17B | -2.34% | 5,095,051 | 934.66M |
| 208 | ZLAB | Zai Lab Limited | 3.16B | 12.74% | 1,894,887 | 441.73M |
| 209 | PRVA | Privia Health Group, Inc. | 3.12B | 2.05% | 2,807,725 | 2.43B |
| 210 | TMDX | TransMedics Group, Inc. | 3.07B | 27.98% | 3,950,694 | 727.65M |
| 211 | BHC | Bausch Health Companies Inc. | 3.06B | 2.83% | 2,818,248 | 11.11B |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | 1.96% | 1,652,526 | 36.54M |
| 213 | SGRY | Surgery Partners, Inc. | 3.01B | 0.06% | 3,114,292 | 3.37B |
| 214 | AXGN | Axogen, Inc. | 2.98B | 2.48% | 1,222,778 | 266.93M |
| 215 | ATRC | AtriCure, Inc. | 2.98B | -4.52% | 614,650 | 589.80M |
| 216 | IRTC | iRhythm Holdings, Inc. | 2.94B | -31.41% | 5,466,129 | 854.04M |
| 217 | AVAH | Aveanna Healthcare Holdings Inc. | 2.89B | -3.04% | 1,804,246 | 2.60B |
| 218 | ADMA | ADMA Biologics, Inc. | 2.82B | -3.67% | 4,647,306 | 519.15M |
| 219 | VCEL | Vericel Corporation | 2.79B | 5.39% | 1,612,191 | 324.17M |
| 220 | XERS | Xeris Biopharma Holdings, Inc. | 2.78B | 16.21% | 7,890,967 | 368.26M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.68B | 6.30% | 1,085,461 | 1.46B |
| 222 | XNCR | Xencor, Inc. | 2.68B | 5.05% | 1,115,815 | 200.49M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.63B | 2.05% | 1,982,764 | 146.64M |
| 224 | RCUS | Arcus Biosciences, Inc. | 2.63B | 3.28% | 1,055,345 | 100.00M |
| 225 | HCM | HUTCHMED (China) Limited | 2.63B | 6.90% | 157,312 | 549.12M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.63B | 0.57% | 207,237 | - |
| 227 | PGNY | Progyny, Inc. | 2.61B | 1.47% | 1,548,515 | 1.34B |
| 228 | CLOV | Clover Health Investments, Corp. | 2.58B | 7.81% | 7,548,921 | 2.74B |
| 229 | NEOG | Neogen Corporation | 2.57B | 0.68% | 2,408,511 | 884.00M |
| 230 | PVLA | Palvella Therapeutics, Inc. | 2.54B | 12.22% | 502,011 | - |
| 231 | MBX | MBX Biosciences, Inc. | 2.47B | 5.88% | 488,156 | - |
| 232 | ARDT | Ardent Health, Inc. | 2.44B | 8.77% | 3,465,542 | 6.45B |
| 233 | PHVS | Pharvaris N.V. | 2.41B | 5.55% | 333,493 | - |
| 234 | MD | Pediatrix Medical Group, Inc. | 2.38B | -2.01% | 491,179 | 1.96B |
| 235 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 5.77% | 926,313 | 158.00K |
| 236 | UFPT | UFP Technologies, Inc. | 2.32B | 0.03% | 103,673 | 649.52M |
| 237 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 7.46% | 427,884 | - |
| 238 | SEPN | Septerna, Inc. | 2.28B | 3.08% | 384,546 | 98.88M |
| 239 | ADUS | Addus HomeCare Corporation | 2.26B | -2.28% | 276,626 | 1.50B |
| 240 | NAMS | NewAmsterdam Pharma Company N.V. | 2.26B | -0.03% | 1,519,283 | 25.94M |
| 241 | SDGR | Schrödinger, Inc. | 2.24B | 3.58% | 1,427,378 | 269.20M |
| 242 | TRLV | Trulieve Cannabis Corp. | 2.22B | 5.87% | 1,550,683 | 1.08B |
| 243 | IMNM | Immunome, Inc. | 2.21B | 4.52% | 1,332,926 | 4.02M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.57% | 1,070,619 | 321.74M |
| 245 | PRGO | Perrigo Company plc | 2.20B | 0.89% | 2,314,618 | 4.09B |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 0.43% | 15,543,088 | 68.23M |
| 247 | BHVN | Biohaven Ltd. | 2.19B | 4.10% | 2,921,346 | - |
| 248 | NEO | NeoGenomics, Inc. | 2.18B | 2.18% | 1,314,036 | 787.75M |
| 249 | LKFT | Lakefront Biotherapeutics NV | 2.16B | -0.27% | 374,097 | 1.13B |
| 250 | VERA | Vera Therapeutics, Inc. | 2.16B | -1.09% | 2,078,168 | 10.28M |
| 251 | BKD | Brookdale Senior Living Inc. | 2.15B | -16.60% | 25,481,962 | 2.93B |
| 252 | FTRE | Fortrea Holdings Inc. | 2.12B | 7.28% | 1,941,746 | 2.67B |
| 253 | ZYME | Zymeworks Inc. | 2.10B | 3.18% | 903,143 | 37.13M |
| 254 | VIR | Vir Biotechnology, Inc. | 2.09B | 10.71% | 1,895,251 | 302.80M |
| 255 | REPL | Replimune Group, Inc. | 2.05B | 8.02% | 2,971,963 | - |
| 256 | TRVI | Trevi Therapeutics, Inc. | 2.04B | 11.83% | 2,545,649 | - |
| 257 | PBH | Prestige Consumer Healthcare Inc. | 2.04B | -2.92% | 1,127,190 | 1.17B |
| 258 | TRAX | First Tracks Biotherapeutics, Inc. | 2.01B | 5.33% | 587,920 | - |
| 259 | ESTA | Establishment Labs Holdings Inc. | 1.99B | 3.90% | 321,677 | 264.03M |
| 260 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.98B | 0.72% | 5,210,622 | 961.51M |
| 261 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.95B | 7.74% | 1,936,351 | 213.00M |
| 262 | VCYT | Veracyte, Inc. | 1.95B | 0.58% | 6,580,542 | 581.78M |
| 263 | ALMR | Alamar Biosciences, Inc. | 1.95B | 4.11% | 536,160 | 114.05M |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 2.00% | 787,076 | 989.36M |
| 265 | AGL | agilon health, inc. | 1.91B | -0.10% | 289,720 | 6.00B |
| 266 | XRAY | DENTSPLY SIRONA Inc. | 1.89B | -6.00% | 10,284,336 | 3.58B |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 1.51% | 2,596,185 | 1.96B |
| 268 | WGS | GeneDx Holdings Corp. | 1.86B | -3.20% | 1,204,342 | 454.43M |
| 269 | INSP | Inspire Medical Systems, Inc. | 1.85B | -3.79% | 490,598 | 880.94M |
| 270 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -3.26% | 326,440 | 269.36M |
| 271 | MAZE | Maze Therapeutics, Inc. | 1.85B | 5.20% | 493,451 | 20.00M |
| 272 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 9.02% | 543,966 | 11.00M |
| 273 | CERT | Certara, Inc. | 1.84B | -1.23% | 4,871,017 | 425.76M |
| 274 | MESO | Mesoblast Limited | 1.83B | 1.17% | 192,807 | 120.25M |
| 275 | NVAX | Novavax, Inc. | 1.78B | 10.12% | 6,284,166 | 411.65M |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 1.76B | 3.96% | 1,281,175 | 140.84M |
| 277 | LYCA | Lycia Therapeutics, Inc. | 1.75B | 5.59% | 369,984 | 4.44M |
| 278 | ABSI | Absci Corporation | 1.75B | 8.31% | 3,763,981 | 1.56M |
| 279 | ALVO | Alvotech | 1.73B | 6.81% | 1,015,933 | 494.61M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.73B | 1.65% | 1,160,111 | 28.21M |
| 281 | OMCL | Omnicell, Inc. | 1.72B | -1.75% | 562,784 | 1.24B |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.72B | 1.10% | 353,506 | 106.73M |
| 283 | AZTA | Azenta, Inc. | 1.72B | 4.83% | 792,082 | 613.81M |
| 284 | PSNL | Personalis, Inc. | 1.71B | 1.51% | 3,000,098 | 80.77M |
| 285 | BFLY | Butterfly Network, Inc. | 1.70B | 4.86% | 3,473,634 | 123.26M |
| 286 | ASTH | Astrana Health, Inc. | 1.70B | -11.56% | 1,063,724 | 3.91B |
| 287 | SLS | SELLAS Life Sciences Group, Inc. | 1.70B | 6.79% | 7,606,413 | - |
| 288 | KLRA | Kailera Therapeutics, Inc. | 1.68B | 6.57% | 733,038 | - |
| 289 | GENB | Generate Biomedicines, Inc. | 1.67B | 3.82% | 632,059 | 26.48M |
| 290 | NRIX | Nurix Therapeutics, Inc. | 1.67B | 3.10% | 2,974,969 | 701.94M |
| 291 | HCSG | Healthcare Services Group, Inc. | 1.64B | -3.31% | 684,775 | 1.88B |
| 292 | ETON | Eton Pharmaceuticals, Inc. | 1.61B | 19.75% | 1,269,867 | 141.06M |
| 293 | PGEN | Precigen, Inc. | 1.60B | 5.92% | 9,235,321 | 156.94M |
| 294 | IMCR | Immunocore Holdings plc | 1.60B | 9.15% | 1,526,332 | 430.78M |
| 295 | TDOC | Teladoc Health, Inc. | 1.60B | -7.01% | 5,725,504 | 2.47B |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 2.34% | 4,402,169 | 52.89M |
| 297 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | -0.96% | 4,049,091 | 730.00M |
| 298 | ENOV | Enovis Corporation | 1.57B | -5.19% | 2,304,733 | 2.31B |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.56B | -3.71% | 1,066,422 | 593.38M |
| 300 | NBTX | Nanobiotix S.A. | 1.56B | 1.93% | 134,389 | 13.15M |
| 301 | NVCR | NovoCure Limited | 1.55B | -2.07% | 976,616 | 725.39M |
| 302 | ALHC | Alignment Healthcare, Inc. | 1.53B | -2.98% | 3,667,882 | 4.94B |
| 303 | CNMD | CONMED Corporation | 1.53B | -2.61% | 331,546 | 1.37B |
| 304 | BRVE | Braveheart Bio, Inc. | 1.52B | 6.72% | 701,538 | - |
| 305 | QURE | uniQure N.V. | 1.50B | 3.19% | 952,009 | 20.17M |
| 306 | USPH | U.S. Physical Therapy, Inc. | 1.50B | 3.06% | 295,067 | 829.86M |
| 307 | DMRA | Damora Therapeutics, Inc. | 1.47B | 8.60% | 360,452 | - |
| 308 | ADRX | ADARx Pharmaceuticals, Inc. | 1.47B | -1.43% | 439,977 | 6.13M |
| 309 | NUVB | Nuvation Bio Inc. | 1.47B | -0.84% | 5,334,787 | 201.73M |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.45B | 1.20% | 862,264 | - |
| 311 | GPCR | Structure Therapeutics Inc. | 1.45B | 6.81% | 1,615,804 | - |
| 312 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 537,093 | 743.30M |
| 313 | KARD | Kardigan, Inc. | 1.45B | 11.94% | 406,386 | - |
| 314 | RAPP | Rapport Therapeutics, Inc. | 1.45B | 2.95% | 866,404 | 20.00M |
| 315 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.49% | 1,956,487 | 52.06M |
| 316 | ANIP | ANI Pharmaceuticals, Inc. | 1.43B | -3.30% | 578,161 | 1.04B |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.41B | 6.11% | 3,182,422 | 5.49M |
| 318 | KRSA | Korsana Biosciences, Inc. | 1.41B | 1.71% | 65,597 | - |
| 319 | AMN | AMN Healthcare Services, Inc. | 1.39B | -24.15% | 1,855,518 | 3.52B |
| 320 | ANAB | AnaptysBio, Inc. | 1.39B | 1.95% | 287,647 | 106.09M |
| 321 | AAPG | Ascentage Pharma Group International | 1.38B | 0.79% | 5,543 | 94.61M |
| 322 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | 0.66% | 1,335,229 | - |
| 323 | INVA | Innoviva, Inc. | 1.36B | -0.83% | 1,654,267 | 438.32M |
| 324 | LBRX | LB Pharmaceuticals Inc | 1.35B | 10.13% | 415,177 | - |
| 325 | PAHC | Phibro Animal Health Corporation | 1.34B | -6.72% | 283,513 | 1.54B |
| 326 | CRON | Cronos Group Inc. | 1.34B | -2.82% | 1,315,928 | 206.20M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.29B | 9.11% | 544,563 | - |
| 328 | LMRI | Lumexa Imaging Holdings, Inc. | 1.29B | 1.51% | 322,848 | 1.04B |
| 329 | OPK | OPKO Health, Inc. | 1.28B | -1.43% | 6,898,909 | 654.10M |
| 330 | PNTG | The Pennant Group, Inc. | 1.28B | -8.70% | 1,122,862 | 1.17B |
| 331 | GHRS | GH Research PLC | 1.28B | 0.92% | 453,631 | - |
| 332 | NKTR | Nektar Therapeutics | 1.27B | 3.02% | 686,441 | 54.59M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.27B | 3.23% | 417,299 | - |
| 334 | STAA | STAAR Surgical Company | 1.27B | -5.65% | 1,036,434 | 328.27M |
| 335 | MNKD | MannKind Corporation | 1.25B | 3.59% | 4,984,958 | 413.37M |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.25B | 5.72% | 220,135 | 1.30M |
| 337 | NUTX | Nutex Health Inc. | 1.24B | -6.66% | 167,920 | 796.53M |
| 338 | SGP | SpyGlass Pharma, Inc. | 1.23B | 7.83% | 109,374 | - |
| 339 | SVRA | Savara Inc. | 1.23B | 10.05% | 2,218,335 | - |
| 340 | OMER | Omeros Corporation | 1.22B | -0.94% | 1,014,198 | 38.42M |
| 341 | INNV | InnovAge Holding Corp. | 1.22B | -1.38% | 750,302 | 1.02B |
| 342 | VOR | Vor Biopharma Inc. | 1.22B | 6.54% | 554,797 | - |
| 343 | URGN | UroGen Pharma Ltd. | 1.21B | -3.81% | 1,735,102 | 250.25M |
| 344 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.21B | 3.36% | 826,252 | 745.79M |
| 345 | GDRX | GoodRx Holdings, Inc. | 1.20B | 0.72% | 1,174,056 | 785.23M |
| 346 | CMPS | COMPASS Pathways plc | 1.19B | 10.24% | 3,757,104 | - |
| 347 | SLN | Silence Therapeutics plc | 1.19B | 0.03% | 958,192 | 615.00K |
| 348 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 1.78% | 1,850,316 | 352.31M |
| 349 | TNDM | Tandem Diabetes Care, Inc. | 1.18B | -6.00% | 5,948,677 | 1.08B |
| 350 | AHG | Akso Health Group | 1.16B | 4.25% | 13,403 | 13.83M |
| 351 | ATEC | Alphatec Holdings, Inc. | 1.16B | -4.49% | 3,199,429 | 839.72M |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 5.25% | 227,029 | - |
| 353 | IRMD | IRADIMED CORPORATION | 1.10B | 0.70% | 222,101 | 89.34M |
| 354 | SIBN | SI-BONE, Inc. | 1.09B | -0.21% | 683,472 | 220.65M |
| 355 | FRNM | Freenome, Inc. | 1.09B | -3.06% | 2,457,101 | 35.41M |
| 356 | JANX | Janux Therapeutics, Inc. | 1.08B | 9.78% | 852,278 | 23.29M |
| 357 | IART | Integra LifeSciences Holdings Corporation | 1.04B | -4.89% | 871,812 | 1.66B |
| 358 | CBLL | CeriBell, Inc. | 1.04B | 2.61% | 436,387 | 108.72M |
| 359 | VSTM | Verastem, Inc. | 1.02B | -10.29% | 7,038,205 | 100.30M |
| 360 | HROW | Harrow, Inc. | 1.01B | 3.46% | 650,833 | 275.59M |
| 361 | CSTL | Castle Biosciences, Inc. | 990.72M | -5.18% | 981,631 | 377.13M |
| 362 | AORT | Artivion, Inc. | 987.75M | -20.08% | 3,246,943 | 481.88M |
| 363 | ANRO | Alto Neuroscience, Inc. | 987.33M | 15.04% | 616,285 | - |
| 364 | MLTX | MoonLake Immunotherapeutics | 982.98M | 6.94% | 1,033,822 | - |
| 365 | AHCO | AdaptHealth Corp. | 981.22M | -0.88% | 2,286,999 | 3.44B |
| 366 | GMRS | GMR Solutions Inc. | 967.64M | -0.48% | 810,034 | 5.88B |
| 367 | JBIO | Jade Biosciences, Inc. | 957.14M | 6.74% | 596,491 | - |
| 368 | IVA | Inventiva S.A. | 940.11M | 4.96% | 2,220,379 | 2.81M |
| 369 | OMDA | Omada Health, Inc. | 935.52M | -20.37% | 4,709,182 | 333.04M |
| 370 | ODTX | Odyssey Therapeutics, Inc. | 921.91M | 1.85% | 577,256 | 99.00K |
| 371 | ORIC | ORIC Pharmaceuticals, Inc. | 913.18M | 3.77% | 556,747 | - |
| 372 | CTY | City Therapeutics, Inc. | 908.06M | 6.91% | 311,821 | 14.34M |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 900.91M | 3.02% | 1,005,563 | 70.33M |
| 374 | BVS | Bioventus Inc. | 893.59M | -0.70% | 642,457 | 585.64M |
| 375 | CRVS | Corvus Pharmaceuticals, Inc. | 888.32M | 8.53% | 1,257,477 | - |
| 376 | HSTM | HealthStream, Inc. | 881.16M | -2.70% | 249,731 | 327.95M |
| 377 | AKTS | Aktis Oncology, Inc. | 879.90M | 6.53% | 362,862 | 10.06M |
| 378 | IMTX | Immatics N.V. | 869.35M | 2.91% | 1,063,382 | 47.65M |
| 379 | MGTX | MeiraGTx Holdings plc | 864.87M | 5.82% | 703,329 | 397.50M |
| 380 | OBX | Obsidian Therapeutics, Inc. | 859.88M | 45.00% | 2,089,578 | - |
| 381 | SNDX | Syndax Pharmaceuticals, Inc. | 857.97M | 1.71% | 3,561,289 | 289.68M |
| 382 | BBNX | Beta Bionics, Inc. | 855.47M | 1.58% | 1,222,765 | 127.27M |
| 383 | PHAR | Pharming Group N.V. | 852.27M | -2.03% | 9,729 | 386.75M |
| 384 | LTGO | Latigo Biotherapeutics, Inc. | 833.38M | -3.38% | 555,386 | - |
| 385 | KIDS | OrthoPediatrics Corp. | 827.18M | -1.68% | 203,975 | 264.14M |
| 386 | PRME | Prime Medicine, Inc. | 824.59M | 4.16% | 3,058,952 | 4.07M |
| 387 | ANNX | Annexon, Inc. | 795.28M | 4.74% | 2,622,003 | - |
| 388 | BBTX | Bambusa Therapeutics, Inc. | 794.19M | -1.64% | 218,961 | - |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 787.57M | 9.94% | 3,598,085 | 38.54M |
| 390 | COLL | Collegium Pharmaceutical, Inc. | 787.52M | -3.86% | 775,369 | 815.19M |
| 391 | PHR | Phreesia, Inc. | 783.34M | -0.71% | 650,323 | 507.79M |
| 392 | ALMS | Alumis Inc. | 777.91M | 2.74% | 1,278,966 | 7.40M |
| 393 | VREX | Varex Imaging Corporation | 777.42M | 0.03% | 467,373 | 865.00M |
| 394 | INMD | InMode Ltd. | 766.79M | -0.45% | 657,825 | 374.63M |
| 395 | CTKB | Cytek Biosciences, Inc. | 763.71M | 8.15% | 1,132,262 | 207.65M |
| 396 | DNA | Ginkgo Bioworks Holdings, Inc. | 758.25M | 13.05% | 2,697,067 | 130.75M |
| 397 | RIGL | Rigel Pharmaceuticals, Inc. | 738.23M | -13.54% | 758,982 | 288.21M |
| 398 | SLDB | Solid Biosciences Inc. | 734.40M | 6.47% | 1,425,498 | - |
| 399 | OABI | OmniAb, Inc. | 732.22M | 3.93% | 1,442,252 | 40.21M |
| 400 | QDEL | QuidelOrtho Corporation | 731.75M | -16.94% | 2,816,778 | 2.59B |
| 401 | IRWD | Ironwood Pharmaceuticals, Inc. | 727.06M | 9.18% | 3,613,546 | 400.30M |
| 402 | CGEM | Cullinan Therapeutics, Inc. | 726.89M | 4.58% | 755,506 | - |
| 403 | ABUS | Arbutus Biopharma Corporation | 723.13M | -0.41% | 1,717,965 | 181.72M |
| 404 | ARDX | Ardelyx, Inc. | 722.70M | -3.85% | 5,447,369 | 468.22M |
| 405 | NVCT | Nuvectis Pharma, Inc. | 720.61M | 15.82% | 255,638 | - |
| 406 | SANA | Sana Biotechnology, Inc. | 704.99M | 0.64% | 2,288,441 | - |
| 407 | PACB | Pacific Biosciences of California, Inc. | 700.92M | -7.20% | 9,531,012 | 161.39M |
| 408 | SGMT | Sagimet Biosciences Inc. | 699.16M | 8.11% | 857,846 | - |
| 409 | ATTO | Attovia Therapeutics, Inc. | 694.81M | 1.47% | 218,754 | 1.80M |
| 410 | ACHV | Achieve Life Sciences, Inc. | 691.50M | 5.57% | 1,075,729 | - |
| 411 | ZVRA | Zevra Therapeutics, Inc. | 690.25M | 10.16% | 1,534,593 | 147.76M |
| 412 | AURA | Aura Biosciences, Inc. | 680.82M | 3.55% | 859,019 | - |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 676.74M | 8.89% | 993,257 | 92.01M |
| 414 | AVBP | ArriVent BioPharma, Inc. | 673.05M | 11.61% | 1,259,242 | - |
| 415 | DBVT | DBV Technologies S.A. | 672.14M | 6.89% | 210,654 | 3.74M |
| 416 | CADL | Candel Therapeutics, Inc. | 669.54M | 8.83% | 953,016 | - |
| 417 | IMMX | Immix Biopharma, Inc. | 666.54M | 11.67% | 1,444,882 | - |
| 418 | ANL | Adlai Nortye Group Ltd. | 665.87M | 6.82% | 531,007 | 18.06M |
| 419 | WVE | Wave Life Sciences, Inc. | 664.66M | 4.50% | 2,205,149 | 70.92M |
| 420 | FLGT | Fulgent Genetics, Inc. | 664.53M | 27.47% | 943,412 | 330.28M |
| 421 | HELP | Helus Pharma Inc. | 653.52M | 6.62% | 1,209,368 | - |
| 422 | KURA | Kura Oncology, Inc. | 645.41M | 6.69% | 3,087,605 | 77.23M |
| 423 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | 8.43% | 1,337,270 | - |
| 424 | DSGN | Design Therapeutics, Inc. | 638.96M | 5.58% | 330,605 | - |
| 425 | APMD | Apnimed, Inc. | 635.29M | 7.77% | 225,337 | 115.12M |
| 426 | GERN | Geron Corporation | 632.77M | 3.38% | 13,651,761 | 217.52M |
| 427 | SOPH | SOPHiA GENETICS SA | 611.60M | 7.85% | 644,479 | 90.97M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 604.44M | 8.03% | 3,526,327 | 6.40M |
| 429 | EVO | Evotec SE | 604.09M | -3.66% | 66,975 | 815.72M |
| 430 | CLYM | Climb Bio, Inc. | 591.59M | 16.12% | 1,139,760 | - |
| 431 | TCMD | Tactile Systems Technology, Inc. | 583.56M | -1.21% | 192,132 | 356.42M |
| 432 | CBIO | Crescent Biopharma, Inc. | 577.39M | 4.25% | 137,756 | 11.88M |
| 433 | BCAX | Bicara Therapeutics Inc. | 572.73M | 5.68% | 1,010,413 | - |
| 434 | FTH | Faeth Therapeutics, Inc. | 567.71M | 10.29% | 534,572 | - |
| 435 | MYGN | Myriad Genetics, Inc. | 565.59M | -6.04% | 2,562,310 | 803.60M |
| 436 | SGHT | Sight Sciences, Inc. | 561.35M | 3.48% | 576,377 | 88.40M |
| 437 | OVID | Ovid Therapeutics Inc. | 557.58M | 10.66% | 3,896,400 | 1.58M |
| 438 | AVR | Anteris Technologies Global Corp. | 554.25M | 1.88% | 1,152,676 | 2.24M |
| 439 | ENTX | Entera Bio Ltd. | 546.12M | 5.02% | 117,899 | 42.00K |
| 440 | NRC | NRC Health | 545.39M | 0.86% | 83,420 | 143.79M |
| 441 | SRZN | Surrozen, Inc. | 539.73M | 6.38% | 140,726 | 11.51M |
| 442 | SLBT | SL Science Holding Limited | 538.27M | 4.87% | 53,694 | 3.27M |
| 443 | CAPR | Capricor Therapeutics, Inc. | 524.41M | 4.88% | 4,639,613 | 11.13M |
| 444 | VALN | Valneva SE | 523.33M | -2.30% | 7,960 | 163.30M |
| 445 | DCTH | Delcath Systems, Inc. | 518.23M | 3.07% | 696,441 | 95.42M |
| 446 | EVH | Evolent Health, Inc. | 517.46M | 0.77% | 1,743,938 | 2.34B |
| 447 | RCEL | AVITA Medical, Inc. | 513.39M | 5.87% | 1,137,548 | 84.68M |
| 448 | GYRE | Gyre Therapeutics, Inc. | 508.58M | 18.45% | 359,716 | 110.06M |
| 449 | INDP | Indaptus Therapeutics, Inc. | 506.82M | 4.43% | 274,438 | - |
| 450 | NGNE | Neurogene Inc. | 506.49M | -1.33% | 324,165 | 925.00K |
| 451 | MCTA | Charming Medical Limited | 504.26M | - | - | 4.81M |
| 452 | DMAC | DiaMedica Therapeutics Inc. | 503.94M | 3.37% | 156,420 | - |
| 453 | RGNX | REGENXBIO Inc. | 502.69M | 3.18% | 1,186,481 | 153.91M |
| 454 | SRTA | Strata Critical Medical, Inc. | 495.73M | 5.51% | 1,354,845 | 280.76M |
| 455 | ANGO | AngioDynamics, Inc. | 493.30M | -0.72% | 363,713 | 325.38M |
| 456 | ETRA | Electra Therapeutics, Inc. | 490.21M | 6.26% | 401,301 | - |
| 457 | MDXG | MiMedx Group, Inc. | 482.28M | 0.76% | 1,106,855 | 303.73M |
| 458 | TKNO | Alpha Teknova, Inc. | 481.28M | -1.02% | 546,512 | 45.95M |
| 459 | MNPR | Monopar Therapeutics Inc. | 480.86M | 6.58% | 92,947 | - |
| 460 | IAM | Iambic Therapeutics, Inc. | 479.22M | -13.14% | 671,628 | 18.25M |
| 461 | CTMX | CytomX Therapeutics, Inc. | 476.11M | 2.10% | 2,727,215 | 14.03M |
| 462 | STTK | Shattuck Labs, Inc. | 463.18M | 2.78% | 1,148,332 | 1.00M |
| 463 | BWAY | BrainsWay Ltd. | 462.63M | 4.90% | 103,038 | 60.70M |
| 464 | OCS | Oculis Holding AG | 461.14M | 9.37% | 404,086 | 1.12M |
| 465 | EOLS | Evolus, Inc. | 454.73M | 1.18% | 1,521,611 | 325.47M |
| 466 | SENS | Senseonics Holdings, Inc. | 453.66M | 7.38% | 786,725 | 48.55M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 453.21M | 4.24% | 585,088 | - |
| 468 | AQST | Aquestive Therapeutics, Inc. | 452.48M | -1.64% | 3,960,875 | 48.84M |
| 469 | MASS | 908 Devices Inc. | 437.31M | 4.24% | 332,773 | 60.84M |
| 470 | SSII | SS Innovations International, Inc. | 430.83M | 13.16% | 87,499 | 52.40M |
| 471 | BLSM | BlossomHill Therapeutics, Inc. | 430.69M | 9.72% | 174,332 | - |
| 472 | NPCE | NeuroPace, Inc. | 429.74M | -1.34% | 128,377 | 106.99M |
| 473 | TLRY | Tilray Brands, Inc. | 428.25M | 3.91% | 4,250,382 | 963.10M |
| 474 | PBYI | Puma Biotechnology, Inc. | 425.61M | -15.61% | 1,279,703 | 231.87M |
| 475 | YDES | YD Bio Limited | 424.28M | -16.57% | 206,530 | 1.24M |
| 476 | SI | Shoulder Innovations, Inc. | 423.04M | -0.25% | 228,737 | 64.49M |
| 477 | ARVN | Arvinas, Inc. | 419.76M | -2.14% | 1,212,726 | 275.30M |
| 478 | RLMD | Relmada Therapeutics, Inc. | 416.55M | 3.58% | 1,055,409 | - |
| 479 | PHAT | Phathom Pharmaceuticals, Inc. | 415.42M | 2.95% | 1,770,845 | 274.88M |
| 480 | ASMB | Assembly Biosciences, Inc. | 414.54M | 1.80% | 249,358 | 74.85M |
| 481 | CRMD | CorMedix Inc. | 413.49M | 1.43% | 1,616,465 | 462.25M |
| 482 | PRTA | Prothena Corporation plc | 409.67M | 1.14% | 421,781 | 52.74M |
| 483 | RZLT | Rezolute, Inc. | 407.00M | 6.59% | 1,520,115 | - |
| 484 | CERS | Cerus Corporation | 406.94M | -5.40% | 2,069,438 | 226.57M |
| 485 | ALT | Altimmune, Inc. | 406.54M | 6.09% | 2,760,619 | 31.00K |
| 486 | KMDA | Kamada Ltd. | 404.85M | 5.09% | 101,812 | 191.85M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 404.09M | 6.44% | 307,949 | - |
| 488 | CARL | Carlsmed, Inc. | 395.89M | -5.35% | 94,479 | 63.30M |
| 489 | EDIT | Editas Medicine, Inc. | 393.93M | 0.59% | 1,715,861 | 47.01M |
| 490 | ZURA | Zura Bio Limited | 392.04M | 9.41% | 3,001,595 | - |
| 491 | MPLT | MapLight Therapeutics, Inc. | 384.58M | 11.25% | 498,549 | - |
| 492 | CTEV | Claritev Corporation | 383.86M | 12.02% | 163,934 | 994.67M |
| 493 | CCCC | C4 Therapeutics, Inc. | 380.15M | 4.75% | 4,325,494 | 32.28M |
| 494 | TRXB | TRex Bio, Inc. | 377.45M | 7.93% | 150,155 | - |
| 495 | AGMB | AgomAb Therapeutics NV | 375.27M | 9.33% | 158,411 | - |
| 496 | CTNM | Contineum Therapeutics, Inc. | 373.03M | 7.83% | 343,535 | - |
| 497 | AVTX | Avalo Therapeutics, Inc. | 372.73M | 4.83% | 1,112,294 | 59.00K |
| 498 | MOBI | Mobia Medical, Inc. | 372.53M | -1.15% | 223,804 | 51.89M |
| 499 | PRLD | Prelude Therapeutics Incorporated | 370.27M | 1.13% | 140,529 | 22.42M |
| 500 | STLN | Starling Oncology, Inc. | 367.17M | -46.27% | 23,878,970 | 620.45M |